top of page

Demographics

About 100 people in the U.S. experience onset of LHON vision loss each year, joining the 4,000 or so in the U.S. who are already legally blind due to LHON. Thousands more are unaffected carriers of an LHON genetic mutation and could suddenly become affected by LHON vision loss at any time. It’s estimated that about 35,000 people worldwide have LHON vision. About 25% of those affected are female, 75% are male. 

A donut chart showing the gender distribution of people affected by LHON. The chart indicates 75% males in dark blue and 25% females in pink, with the label ‘LHON Affected’ in the center.

Onset of vision loss can happen at any age. Females have no peak onset age. Male onset peaks at ages 12-26. Individuals carrying an LHON mutation are never “too young” or “too old” to become affected. Prior to the era of genetic testing, it was estimated that 50% of males who carry an LHON mutation will become affected, and that figure is still commonly quoted. However, recent studies indicate that less than 20% for males and about 5% for females is a better estimate among families with someone affected by vision loss. The risk is substantially lower in families with no one yet affected by vision loss.

Videos and Peer-Reviewed Papers:

Line graph titled ‘Age of Symptom Onset – Males.’ The x-axis shows age from 0 to 80, and the y-axis shows percent of males from 0% to 8%. The curve peaks sharply between ages 15 and 25, with the highest point around age 20, then gradually declines and remains low through later ages.
Line graph titled ‘Age of Symptom Onset – Females.’ The x-axis shows age from 0 to 80, and the y-axis shows percent of females from 0% to 8%. The curve fluctuates between ages 10 and 40, peaking around the early 20s at just under 4%, then gradually declines and remains low through older ages.

Lissa Poincenot, MBA, Alexander L. Pearson, BA., & Rustum Karanjia, MD, PhD (2019). Demographics of a Large International Population of Patients Affected by Leber’s Hereditary Optic Neuropathy. Ophthalmology, 126(12), 1657-1668. Figure 3. https://doi.org/10.1016/j.ophtha.2019.06.021

bottom of page